Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1988Arthritis & Rheumatism

The terminal complement complex, c5b–9, a marker of disease activity in patients with systemic lupus erythematosus

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMaria S. GawrylUniversity of North Carolina at Chapel HillDCDavid S. ChudwinNational Institutes of HealthPLPaul F. Langlois

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gawryl et al. (1988) studied this question.

synapsesocial.com/papers/6a7bfdc8f056b38aaddf83fbhttps://doi.org/10.1002/art.1780310206
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Monoclonal Antibodies Recognizing a Neoantigen of Poly(C9) Detect the Human Terminal Complement Complex in Tissue and Plasma1985 · 202 citations
  2. 2Reassessment of the clinical significance of native dna antibodies in systemic lupus erythematosus1979 · 125 citations
  3. 3Radioimmunoassay of the Attack Complex of Complement in Serum from Patients with Systemic Lupus Erythematosus1985 · 92 citations